Menu Call
Beau Hooks

Beau Hooks / Patient Advocate

Beau is a graduate of Western Illinois University, where he studied political science and history. He joined Drugwatch.com in 2011 and spends time researching drugs and their side effects. He is passionate about helping people who were harmed by Big Pharma’s products and misleading advertising.

Threads of Zimmer Knee Component

Zimmer Recalls 40,000 NexGen Knee Models

Zimmer Manufacturing initiated another sweeping recall on one of its artificial knee implants, the NexGen MIS Tibial Component,...

Granuflo and Naturalyte, dialysis drugs

Louisiana Files Lawsuit against GranuFlo, NaturaLyte maker Fresenius

The state of Louisiana sued Fresenius Medical Care North America and nearly 100 of its clinics statewide after two of its dialysis drugs – NaturaLyte and GranuFlo – were linked to fatal heart attacks,...

New Study Favors Testosterone Therapy, Fails to Look at Low T Products

A recently released study shows that the injectable form of low testosterone drugs do not increase the risk of a heart attack in older men. The study is being touted by companies that make so-called...

Viagra May Increase Melanoma Risk

Study Links Viagra to Dangerous Melanoma

Medical researchers are studying a connection between erectile dysfunction medications and melanoma, a deadly form of skin cancer. Using data from the Health Professionals Follow-Up Study (HPFS),...

Testosterone Lawsuits Consolidated into MDL

Federal Testosterone Lawsuits Consolidated in MDL in Chicago

Federal lawsuits against the makers of AndroGel and other testosterone replacement therapy (TRT) products will be consolidated in the U.S. District Court for the Northern District of Illinois, where...

Marijuana for Medicinal Use

Health Insurance Companies Refuse to Cover Medical Marijuana

Support for medical marijuana is at an all-time high in the United States – a 2013 Fox News poll showed 85 percent of Americans in favor – but there is one industry that won’t budge on the issue:...

1 2 3